학술논문
Efficacy and safety of nilotinib as frontline treatment in elderly (> 65 years) chronic myeloid leukemia patients outside clinical trials
Document Type
Article
Author
Source
In: Annals of Hematology . (Annals of Hematology, June 2023, 102(6):1375-1382)
Subject
Language
English
ISSN
14320584
09395555
09395555